Is anaplastic thyroid cancer an example of epithelial-mesenchymal transition?;Le cancer anaplasique de la thyroïde : un exemple de transition épithélio-mésenchymateuse ?

Annales de Pathologie

Volumn 29, Issue 5 SUPPL.1, 2009, Pages

  Caillou, Bernard ^a   Malouf, Gabriel ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

KERATIN; SODIUM IODIDE SYMPORTER; THYROGLOBULIN; THYROID PEROXIDASE; THYROTROPIN RECEPTOR; UVOMORULIN; VIMENTIN;

ANAPLASTIC CARCINOMA; ARTICLE; DIAGNOSTIC VALUE; EPITHELIUM; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; MESENCHYME; PHENOTYPE; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TISSUE DIFFERENTIATION; TUMOR ASSOCIATED LEUKOCYTE;

ANTIGENS, DIFFERENTIATION; CARCINOMA; CELL TRANSDIFFERENTIATION; EPITHELIAL CELLS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MACROPHAGES; MESODERM; NEOPLASM PROTEINS; THYROID NEOPLASMS;

EID: 73049096821     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annpat.2009.07.036     Document Type: Article

References (12)

1. al-Sarireh B., and Eremin O. Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth. J R Coll Surg Edinb 45 (2000) 1-16
2. Anderson C.F., and Mosser D.M. A novel phenotype for an activated macrophage: the type 2 activated macrophage. J Leukoc Biol 72 (2002) 101-106
3. Aratake Y., Nomura H., Kotani T., Marutsuka K., Kobayashi K., Kuma K., et al. Coexistent anaplastic and differentiated thyroid carcinoma. Am J Clin Pathol 125 (2006) 399-406
4. Are C., and Shaha A.R. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 13 (2006) 453-464
5. Cornett W.R., Sharma A.K., Day T.A., Richardson M.S., Hoda R.S., van Heerden J.A., et al. Anaplastic thyroid carcinoma: an overview. Curr Oncol Rep 9 (2007) 152-158
6. Lin C.Y., Lin C.J., Chen K.H., Wu J.C., Huang S.H., and Wang S.M. Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction. FEBS Lett 580 (2006) 3042-3050
7. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 (2008) 704-715
8. Mantovani A., Allavena P., and Sica A. Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur J Cancer 40 (2004) 1660-1667
9. Mantovani A., Sica A., Allavena P., Garlanda C., and Locati M. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum Immunol 70 (2009) 325-330
10. Oktay M.H., Smolkin M.B., Williams M., and Cajigas A. Metastatic anaplastic carcinoma of the thyroid mimicking squamous cell carcinoma: report of a case of a challenging cytologic diagnosis. Acta Cytol 50 (2006) 201-204
11. Ryder M., Ghossein R.A., Ricarte-Filho J.C., Knauf J.A., and Fagin J.A. Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr Relat Cancer 15 (2008) 1069-1074
12. Wang H.M., Huang Y.W., Huang J.S., Wang C.H., Kok V.C., Hung C.M., et al. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma. Ann Surg Oncol 14 (2007) 3011-3018